Present situation and prospect of PD-1 / PD-L1 inhibitors in the treatment of biliary tract cancer / 中华消化外科杂志
Chinese Journal of Digestive Surgery
;
(12): 219-224, 2018.
Article
Dans Chinois
| WPRIM
| ID: wpr-699103
ABSTRACT
The biliary tract cancer (BTC) is a kind of disease with poor prognosis.Due to the lack of typical clinical manifestations and the effective early diagnosis method,the disease is usually detected at an advanced stage and lost the opportunity of surgical therapy.While the traditional radiotherapy and chemotherapy are limited in the treatment of BTC.The immune system plays an important role in the pathogenesis of BTC.Therefore,the programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors may have great potential value in the treatment of BTC.Authors reviewed the latest literatures and tried to find the current situation and prospect of PD-1 / PD-L1 inhibitors in the treatment of BTC.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Type d'étude:
Étude de dépistage
langue:
Chinois
Texte intégral:
Chinese Journal of Digestive Surgery
Année:
2018
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS